These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 1575174

  • 21. Controlled study with a new sustained-release formulation of nifedipine in essential hypertensive patients.
    Galletti F, Barba G, Nardecchia A, Strazzullo P, Scagliusi P, Pirrelli A, Mancini M.
    J Clin Pharmacol; 1994 Sep; 34(9):919-23. PubMed ID: 7983235
    [Abstract] [Full Text] [Related]

  • 22. Sustained-release nicardipine in mild-to-moderate hypertension.
    Fagan TC, Tyler ED, Reitman MA, Kenley S, Weber MA.
    Chest; 1993 Aug; 104(2):427-33. PubMed ID: 8339631
    [Abstract] [Full Text] [Related]

  • 23. Comparison of effects of controlled onset extended release verapamil at bedtime and nifedipine gastrointestinal therapeutic system on arising on early morning blood pressure, heart rate, and the heart rate-blood pressure product.
    White WB, Black HR, Weber MA, Elliott WJ, Bryzinski B, Fakouhi TD.
    Am J Cardiol; 1998 Feb 15; 81(4):424-31. PubMed ID: 9485131
    [Abstract] [Full Text] [Related]

  • 24. Nifedipine controlled-release 40 mg b.i.d. in Japanese patients with essential hypertension who responded insufficiently to nifedipine controlled-release 40 mg q.d.: a phase III, randomized, double-blind and parallel-group study.
    Shimamoto K, Hasebe N, Ito S, Kario K, Kimura K, Dohi Y, Kawano Y, Rakugi H, Horiuchi M, Imaizumi T, Ohya Y.
    Hypertens Res; 2014 Jan 15; 37(1):69-75. PubMed ID: 23945965
    [Abstract] [Full Text] [Related]

  • 25. [Comparison of amlodipine and the nifedipine retard preparation in the treatment of arterial hypertension].
    Pivac N, Dobovisek J, Bagatin J, Gros Furek V, Rumboldt Z, Janezić A, Kveder R, Sjerobabski V, Simunić M, Sardelić S.
    Lijec Vjesn; 1993 Jan 15; 115(11-12):356-9. PubMed ID: 8176999
    [Abstract] [Full Text] [Related]

  • 26. Antihypertensive efficacy of a slow release nifedipine tablet formulation given once daily in patients with mild to moderate hypertension. A placebo-controlled, double-blind parallel-group trial.
    Harder S, Rietbrock S, Thürmann P.
    Arzneimittelforschung; 1994 Feb 15; 44(2):133-6. PubMed ID: 8147945
    [Abstract] [Full Text] [Related]

  • 27. Prospective controlled trial of two nifedipine extended release formulations in the treatment of essential hypertension.
    Pivac N, Naranca M, Vujic-Podlipec D, Bagatin J, Rumboldt Z.
    Arzneimittelforschung; 2002 Feb 15; 52(5):379-84. PubMed ID: 12087923
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of enalapril versus extended-release nifedipine for the treatment of mild-to-moderate essential hypertension: a multicenter 22-week study. Multicenter Cooperative Study Group.
    Leon AS.
    Clin Ther; 1993 Feb 15; 15(6):1094-107. PubMed ID: 8111807
    [Abstract] [Full Text] [Related]

  • 29. Nifedipine gastrointestinal therapeutic system in the treatment of hypertension. Results of a multicenter trial. The Modern Approach to the Treatment of Hypertension (MATH) Study Group.
    Krakoff LR, Bravo EL, Tuck ML, Friedman CP.
    Am J Hypertens; 1990 Dec 15; 3(12 Pt 2):318S-325S. PubMed ID: 2078318
    [Abstract] [Full Text] [Related]

  • 30. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
    Messerli FH, Oparil S, Feng Z.
    Am J Cardiol; 2000 Dec 01; 86(11):1182-7. PubMed ID: 11090788
    [Abstract] [Full Text] [Related]

  • 31. A comparative study of long acting diltiazem (Tildiem LA) with sustained release nifedipine (nifedipine SR) and bendrofluazide in the treatment of mild to moderate hypertension.
    Hosie J, Nasar MA, Belgrave GP, Walters EG.
    Acta Cardiol; 1994 Dec 01; 49(3):251-65. PubMed ID: 7941918
    [Abstract] [Full Text] [Related]

  • 32. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr 01; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW.
    Clin Ther; 2009 Sep 01; 31(9):1946-56. PubMed ID: 19843484
    [Abstract] [Full Text] [Related]

  • 34. Comparison of the efficacy and safety of trandolapril and nifedipine SR in mild-to-moderate hypertension. Investigator Study Group.
    Steiner G, Pauly NC.
    J Cardiovasc Pharmacol; 1994 Sep 01; 23 Suppl 4():S81-5. PubMed ID: 7527108
    [Abstract] [Full Text] [Related]

  • 35. Ambulatory blood pressure profiles in essential hypertensives after treatment with a new once daily nifedipine formulation.
    Nold G, Herholz C, Sturm M, Hopf R, Lemmer B.
    J Hum Hypertens; 1999 Mar 01; 13(3):173-7. PubMed ID: 10204813
    [Abstract] [Full Text] [Related]

  • 36. Nifedipine gastrointestinal therapeutic system versus nifedipine coat-core: comparison of efficacy via 24-hour ambulatory blood pressure monitoring.
    Defina LF, Bookstaver DA, Goldfinger MP, Coffey TA.
    Ann Pharmacother; 1997 Mar 01; 31(7-8):819-22. PubMed ID: 9220037
    [Abstract] [Full Text] [Related]

  • 37. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
    Luque Otero M, Martell Claros N, Study Investigators Group.
    Clin Ther; 2005 Feb 01; 27(2):166-73. PubMed ID: 15811479
    [Abstract] [Full Text] [Related]

  • 38. Side effects of dihydropyridine therapy: comparison of amlodipine and nifedipine retard.
    Hosie J, Bremner AD, Fell PJ, James GV, Saul PA, Taylor SH.
    J Cardiovasc Pharmacol; 1993 Feb 01; 22 Suppl A():S9-12. PubMed ID: 7522287
    [Abstract] [Full Text] [Related]

  • 39. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
    Lefebvre J, Poirier L, Archambault F, Jewell D, Reed CV, Lacourcière Y.
    Can J Cardiol; 1998 May 01; 14(5):682-8. PubMed ID: 9627524
    [Abstract] [Full Text] [Related]

  • 40. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group.
    Zanchetti A.
    J Hypertens Suppl; 1994 Jul 01; 12(5):S23-7. PubMed ID: 7965282
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.